Determination of ErbB2 protein in breast cancer tissues by different methods. Relationships with other biological parameters

Breast Cancer Research and Treatment

Volumn 37, Issue 3, 1996, Pages 267-276

  Piffanelli, A ^a   Dittadi, R ^b   Catozzi, L ^a   Gion, M ^b   Capitanio, G ^b   Gelli, M C ^c   Brazzale, A ^b   Malagutti, R ^a   Pelizzola, D ^a   Menegon, A ^b   Giovannini, G ^a   Gardini, G ^c  

^a UNIVERSITY OF FERRARA   (Italy)

^b GENERAL HOSPITAL   (Italy)

^c General Hospital   (Italy)

Author keywords

Breast cancer; erbB2; Immunoenzymatic assays; Immunohistochemistry; Prognostic factor; Western blotting

Indexed keywords

ESTROGEN RECEPTOR; ONCOPROTEIN; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BLOTTING, WESTERN; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 1542741308     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806508     Document Type: Article

References (24)

1. Di Fiore PP, Pierce JH, Kraus MH, Segatto O, King CR, Aaronson SA: erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237: 178-182, 1987
2. Pierce LJ, Merino MJ, D'Angelo T, Barker EA, Gilbert L, Cowan KH, Steinberg SM, Glatstein E: Is c-erbB2 a predictor for recurrent disease in early stage breast cancer? Int J Radiat Oncology Biol Phys 28: 395-403, 1994
3. Ciocca DR, Fujimura EK, Tandon AK, Clark GM, Mark C, Lee-Chen GJ, Pounds GW, Vendely P, Owens MA, Pandian MR. McGuire WL: Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers. J Natl Cancer Inst 16: 1279, 1992
4. Tommasi S, Paradiso A, Serlo G, Barletta A, Mangia A, Giannella C, De Lena M: Different assays for HER-2/neu evaluation in breast cancer. Tumori 78: 106-110, 1992
5. Tsuda H, Hirohashi S, Shimosato Y, Tanaka Y, Hirota T, Tsugane S, Shiraishi M, Toyoshima K, Yamamoto T, Terada M, Sugimura T: Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients. Jpn J Cancer Res 81: 327-332, 1990
6. Tiwari RK, Borgen PI, Wong GY, Cordon-Cardo C, Osborne MP: HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis. Anticancer Res 12: 419-426, 1992
7. Borresen AL, Ottestad L, Gaustad A, Andersen TI, Heikkilä R, Jahnsen T, Tveit KM, Nesland JM: Amplification and protein over-expression of the neu-HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis. Br J Cancer 62: 585-590, 1990
8. Iglehart JD, Kraus MH, Langton BC, Huper G, Kerns BJ, Marks JR: Increased erbB-2 gene copies and expression in multiple stages of breast cancer. Cancer Res 50: 6701-6707, 1990
9. Molina R, Ciocca DR, Tandon AK, Allred DC, Clark GM, Chamness GC, Gullick WJ, McGuire WL: Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and Western blot techniques. Anticancer Res 12: 1965-1972, 1992
10. Kerns BJM, Pence JC, Huper G, Kinney RB, Iglehart JD: c-erbB-2 expression in breast cancer detected by immunoblotting and immunohistochemistry. J Histochem Cytochem 38: 1823-1830, 1990
11. neu quantitation in breast cancer specimens. Anticancer Res 13: 1821-1824, 1993
12. EORTC Breast Cancer Cooperative Group: Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 16: 1513-1516, 1980
13. Van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, D'Alesio O, Nusse R: Neu-protein overexpression in breast cancer. N Engl J Med 319: 1239-1245, 1988
14. Laemmli UK: Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970
15. Towbin H, Stahelin T, Gordon J: Electrophoretic transfer of proteins from gels to nitrocellulose sheets. Proc Natl Acad Sci USA 76: 4350-4354, 1979
16. Dittadi R, Donisi PM, Brazzale A, Marconato A, Spina M, Gion M: Immunoenzymatic assay of erbB2 protein in cancer and non-malignant breast tissue. Relationships with clinical and biochemical parameters. Anticancer Res 12: 2005-2010, 1992
17. Langton BC, Crenshaw MC, Chao LA, Stuart SG, Akita RW: An antigen immunologically related to the external domain of gp185 is shed from nude mouse tumors overexpressing the c-erbB2 (HER-2/neu) oncogene. Cancer Res 51: 2593-2598, 1991
18. Bradford M: A rapid sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 72: 248-256, 1976
19. Nugent A, McDermott E, Duffy K, O'Higgins N, Fennelly JJ, Duffy MJ: Enzyme-linked immunosorbent assay of c-erbB-2 oncoprotein in breast cancer. Clin Chem 38/8: 1471-1474, 1992
20. Dawkins HJS, Robbins PD, Sarna M, Carello S, Harvey JM, Sterrett GP: c-erbB-2 amplification and overexpression in breast cancer - evaluation and comparison of Southern blot, slot blot. ELISA and immunohistochemistry. Pathology 25/2: 124-132, 1993
21. Wilbur DC, Barrow GH: Estrogen and progesteron receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study. Modern Pathology 6/2: 114-120, 1993
22. Perren TJ: c-erbB-2 oncogene: a prognostic marker in breast cancer. Br J Cancer 63: 328-332, 1991
23. Press MF, Hung G, Godolphin W, Slamon DJ: Sensitivity of HER-2/neu antibodies in archivial tissue samples: potential sources of error in immunohistochemical studies of oncogene expression. Cancer Research 54: 2771-2777, 1994
24. McGuire WL: Breast cancer prognostic factors: Evaluation guidelines. J Natl Cancer Inst 83/3: 154-155, 1991